Title : Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Pub. Date : 2020 Aug 28

PMID : 32856298






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Oral 5-aminosalicylic acid (5-ASA; also known as mesalazine or mesalamine) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Mesalamine aspartic peptidase retroviral like 1 Homo sapiens
2 BACKGROUND: Oral 5-aminosalicylic acid (5-ASA; also known as mesalazine or mesalamine) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Mesalamine aspartic peptidase retroviral like 1 Homo sapiens
3 BACKGROUND: Oral 5-aminosalicylic acid (5-ASA; also known as mesalazine or mesalamine) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Mesalamine aspartic peptidase retroviral like 1 Homo sapiens
4 BACKGROUND: Oral 5-aminosalicylic acid (5-ASA; also known as mesalazine or mesalamine) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Mesalamine aspartic peptidase retroviral like 1 Homo sapiens